Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03963817

A Snapshot Adaptive Optics and Hyperspectral Autofluorescence Fundus Camera for Age-Related Macular Degeneration (AMD)

Sponsor: Icahn School of Medicine at Mount Sinai

View on ClinicalTrials.gov

Summary

This study proposes to use a new instrument (AO-OCT/AF: adaptive optics - optical coherence tomography/autofluorescence) combined with a data processing method to image the retinal pigment epithelium (RPE) of the eye in normal subjects and in subjects with age-related macular degeneration. (AMD). While currently there is no cure, with early diagnosis, vision loss can be slowed. The technology being developed for this project will be the first imaging modality that can provide both structural and molecular information about the retina in vivo and in 3D.

Official title: Snapshot 3D Ultra-high-resolution OCT and Hyperspectral AF of In-vivo Retina

Key Details

Gender

All

Age Range

60 Years - 90 Years

Study Type

OBSERVATIONAL

Enrollment

50

Start Date

2023-09-06

Completion Date

2027-12

Last Updated

2026-02-24

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

adaptive optics AO-OCT/AF instrument

Using the new adaptive optics AO-OCT/AF instrument, the study team will image 10 normal subjects in order to optimize image acquisition and interpretation.

DIAGNOSTIC_TEST

adaptive optics AO-OCT/AF instrument

Using the new adaptive optics AO-OCT/AF instrument, the study team will image 40 adult subjects with age-related macular degeneration (AMD) who have non-neovascular AMD and soft drusen or subretinal drusenoid deposits in the macula.

Locations (1)

New York Eye and Ear Infirmary of Mount Sinai

New York, New York, United States